The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
about
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulinClipR-59 interacts with Akt and regulates Akt cellular compartmentalizationNEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domainRegulation and cellular roles of ubiquitin-specific deubiquitinating enzymesStructural basis for tubulin recognition by cytoplasmic linker protein 170 and its autoinhibitionThree-Dimensional Structure of CAP-Gly Domain of Mammalian Dynactin Determined by Magic Angle Spinning NMR Spectroscopy: Conformational Plasticity and Interactions with End-Binding Protein EB1Molecular basis for specificity of the Met1-linked polyubiquitin signalSolution structure of the human ubiquitin-specific protease 15 DUSP domainSpecificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transductionEpstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.CYLD-mediated signaling and diseases.Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signalingCLIPR-59 regulates TNF-α-induced apoptosis by controlling ubiquitination of RIP1.CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early EmbryogenesisA Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.HSV ICP0 recruits USP7 to modulate TLR-mediated innate responseAtomic-resolution structure of the CAP-Gly domain of dynactin on polymeric microtubules determined by magic angle spinning NMR spectroscopy.Molecular basis of NF-κB signalingReverse the curse--the role of deubiquitination in cell cycle control.Deubiquitylation and regulation of the immune response.CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.Multifaceted roles of TRIM38 in innate immune and inflammatory responses.Structural studies of NF-κB signaling.Deubiquitinases and the new therapeutic opportunities offered to cancer.DUBs, the regulation of cell identity and disease.Cylindromatosis--A Protective Molecule against Liver Diseases.Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer.Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Prion protein is required for tumor necrosis factor alpha (TNFα)-triggered nuclear factor kappa B (NF-κB) signaling and cytokine production.Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity.The B-box module of CYLD is responsible for its intermolecular interaction and cytoplasmic localization.Novel substitution and frameshift mutations of CYLD in two Chinese families with multiple familial trichoepithelioma.The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration.The novel microtubule-associated CAP-glycine protein Cgp1 governs growth, differentiation, and virulence of Cryptococcus neoformans.
P2860
Q24314876-49F00521-077D-4E45-B79C-5A7E1886AF94Q24316193-E1A0D47A-674F-4AA0-98B6-9ED84936DE7FQ24317367-727FD556-2A42-4A51-9D40-A71402929E87Q24645701-28E6C29A-0041-4D2E-8C82-897F8A5A6DE5Q27645613-FE55F265-5E7C-48B0-B64F-4E1E5A12D459Q27678013-44F1EE03-1E0D-4831-A90E-CAED7C7997CEQ28072740-D9ABD79E-F723-424F-8243-7154CA981AD8Q28282716-AB1F45DE-CF5B-49CD-AC27-599572D79F1DQ30014849-D1BB0E9B-336D-4F22-8714-AD29F838E9AEQ34241279-F5197633-689E-4BCD-AE0B-4AD823B58F99Q35098644-443C80A0-5D7D-4339-B09A-0E544D4835EFQ35565726-63C62C72-9E60-451B-8F80-ABB9385A66B1Q35625506-397E6D4D-78C1-49F7-BAAB-060A8F4CE0DEQ35783607-9BEE5103-0124-475E-A12A-C607116FF5C3Q36065243-A513AF72-EFB1-4F7E-819C-246883CC1570Q36076152-0736302D-E66C-4364-805A-8AE604B88555Q36105979-369AB214-E55E-47DD-942B-40668BAAB41EQ36331907-2D98AC39-99FA-43D8-B60A-5A18422812C9Q36918115-467A96DE-5A9B-4B8C-B440-A4C80152AEBBQ37112275-C766A01D-537E-4015-B9FC-49F1609B4E7AQ37184075-3AF28924-8210-40CC-BE05-3E2EAA5F5068Q37448141-DAE4BD2D-FA45-4A3A-A244-5366ABBFD740Q37543886-2B4A72A8-99D3-4842-BF62-3E4F49EA2178Q37737825-75FA6E19-37AC-4681-96CE-AF3EE8196AEEQ37816940-2D0BC5D3-FC89-4B5F-87D1-098EF8D24C29Q38326071-C5E851BC-695F-44A2-99AE-5EFCCD76FF5DQ38336126-76B0CC2E-6D67-4712-BDA7-C8894CF660ECQ38695458-27C08069-0E04-4CBA-BFAB-20EB99E3C334Q38699941-D4CAC5AF-CF81-48DE-9915-883B1532A5AEQ39098951-3E4B83B2-ED59-4DD8-97DE-7D720EC4AD31Q39210955-89BFB5B3-067B-4506-A3B7-B2580171E608Q40044695-5E82A09D-FEE4-4B6D-8431-84C1BA30354FQ41077731-47D5342A-EF80-42C0-96B1-56FF8FAEB239Q41612503-58D9322D-0047-4065-936C-D9325D7145CDQ42526035-E28DD618-F179-4EE5-BF57-00DA4A746E83Q46789192-9CE7B589-479B-443B-88D2-BF2F6F27E0D3Q48507287-DD2471FB-61D8-4821-B2BC-827274B89702
P2860
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@ast
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@en
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@nl
type
label
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@ast
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@en
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@nl
prefLabel
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@ast
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@en
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@nl
P2093
P50
P921
P1433
P1476
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma
@en
P2093
Akiko Tanaka
Ayako Sakamoto
Emi Nunokawa
Kazuo Sato
Kohei Saito
Makoto Inoue
Manabu Nakayama
Masaaki Aoki
Noriko Hirakawa
P304
P356
10.1016/J.STR.2004.07.012
P407
P577
2004-09-01T00:00:00Z